Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review
Abstract Background Omalizumab is a valuable alternative treatment for allergic bronchopulmonary aspergillosis (ABPA). The effectiveness and safety of this medication have not been confirmed. The main purpose of this study was to evaluate the effectiveness and safety of omalizumab for ABPA. Methods...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2023-10-01
|
| Col·lecció: | BMC Pulmonary Medicine |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12890-023-02696-x |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|